Mas Advisors LLC Gilead Sciences, Inc. Transaction History

Mas Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 04, 2024	BUY	$77.31 - $88.08 $12,446 - $14,180	161 Added 4.33%	3,877 $321,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $12,446 - $14,180	161 Added 4.33%	3,877 $321,000
Q4 2022 Sep 04, 2024	BUY	$62.32 - $89.47 $231,581 - $332,470	3,716 New	3,716 $319,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $25,800 - $37,040	414 Added 12.54%	3,716 $319,000
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $196,601 - $224,569	3,302 New	3,302 $204,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mas Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mas Advisors LLC with notifications on news.